
NeuroMetrix, Inc. – NASDAQ:NURO
NeuroMetrix stock price today
NeuroMetrix stock price monthly change
NeuroMetrix stock price quarterly change
NeuroMetrix stock price yearly change
NeuroMetrix key metrics
Market Cap | 7.88M |
Enterprise value | N/A |
P/E | -2.33 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 1.38 |
Price/Book | 0.48 |
PEG ratio | 0.02 |
EPS | -5.97 |
Revenue | 5.27M |
EBITDA | -8.64M |
Income | -7.98M |
Revenue Q/Q | -36.59% |
Revenue Y/Y | -31.36% |
Profit margin | -53.5% |
Oper. margin | -57.43% |
Gross margin | 69.65% |
EBIT margin | -57.43% |
EBITDA margin | -164.05% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuroMetrix stock price history
NeuroMetrix stock forecast
NeuroMetrix financial statements
Jun 2023 | 1.65M | -1.53M | -92.83% |
---|---|---|---|
Sep 2023 | 1.20M | -1.76M | -147.01% |
Dec 2023 | 1.31M | -1.64M | -125.18% |
Mar 2024 | 1.09M | -3.02M | -277.04% |
Jun 2023 | 22773503 | 1.36M | 5.98% |
---|---|---|---|
Sep 2023 | 21286772 | 1.38M | 6.5% |
Dec 2023 | 21424441 | 1.33M | 6.22% |
Mar 2024 | 20664128 | 1.90M | 9.23% |
Jun 2023 | -1.45M | 237.27K | 700.12K |
---|---|---|---|
Sep 2023 | -2.06M | 1.65M | 1.42K |
Dec 2023 | -1.45M | 97.99K | 1.62M |
Mar 2024 | -2.08M | 138.28K | 1.47M |
NeuroMetrix alternative data
Aug 2023 | 27 |
---|---|
Sep 2023 | 27 |
Oct 2023 | 27 |
Nov 2023 | 27 |
Dec 2023 | 27 |
Jan 2024 | 27 |
Feb 2024 | 27 |
Mar 2024 | 26 |
Apr 2024 | 26 |
May 2024 | 26 |
Jun 2024 | 26 |
Jul 2024 | 26 |
NeuroMetrix other data
Period | Buy | Sel |
---|---|---|
Apr 2024 | 0 | 1000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | HIGGINS THOMAS T officer: Senior Vice President,.. | Common Stock | 498 | $4.47 | $2,226 | ||
Option | HIGGINS THOMAS T officer: Senior Vice President,.. | Restricted Stock Unit | 498 | $4.47 | $2,226 | ||
Option | GOZANI SHAI director, officer.. | Common Stock | 636 | $4.47 | $2,843 | ||
Option | GOZANI SHAI director, officer.. | Restricted Stock Unit | 636 | $4.47 | $2,843 | ||
Option | FLUEGEL BRADLEY M director | Common Stock | 5,396 | $4.37 | $23,581 | ||
Option | FLUEGEL BRADLEY M director | Restricted Stock Unit | 5,396 | $4.37 | $23,581 | ||
Option | VAN AVERMAETE DAVID director | Common Stock | 5,396 | $4.37 | $23,581 | ||
Option | VAN AVERMAETE DAVID director | Restricted Stock Unit | 5,396 | $4.37 | $23,581 | ||
Option | GOODMAN DAVID director | Common Stock | 5,396 | $4.37 | $23,581 | ||
Option | GOODMAN DAVID director | Restricted Stock Unit | 5,396 | $4.37 | $23,581 |
Quarter | Transcript |
---|---|
Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 27 Oct 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
Q1 2023 3 May 2023 | Q1 2023 Earnings Call Transcript |
-
What's the price of NeuroMetrix stock today?
One share of NeuroMetrix stock can currently be purchased for approximately $4.58.
-
When is NeuroMetrix's next earnings date?
Unfortunately, NeuroMetrix's (NURO) next earnings date is currently unknown.
-
Does NeuroMetrix pay dividends?
No, NeuroMetrix does not pay dividends.
-
How much money does NeuroMetrix make?
NeuroMetrix has a market capitalization of 7.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 28.52% to 5.9M US dollars.
-
What is NeuroMetrix's stock symbol?
NeuroMetrix, Inc. is traded on the NASDAQ under the ticker symbol "NURO".
-
What is NeuroMetrix's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of NeuroMetrix?
Shares of NeuroMetrix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NeuroMetrix's key executives?
NeuroMetrix's management team includes the following people:
- Mr. Thomas T. Higgins Senior Vice President, Chief Financial Officer & Treasurer(age: 73, pay: $150,000)
- Dr. Shai N. Gozani Founder, Chairman, Chief Executive Officer, Pres & Sec.(age: 60, pay: $35,780)
-
Is NeuroMetrix founder-led company?
Yes, NeuroMetrix is a company led by its founder Dr. Shai N. Gozani.
-
How many employees does NeuroMetrix have?
As Jul 2024, NeuroMetrix employs 26 workers.
-
When NeuroMetrix went public?
NeuroMetrix, Inc. is publicly traded company for more then 21 years since IPO on 22 Jul 2004.
-
What is NeuroMetrix's official website?
The official website for NeuroMetrix is neurometrix.com.
-
Where are NeuroMetrix's headquarters?
NeuroMetrix is headquartered at 4B Gill Street, Woburn, MA.
-
How can i contact NeuroMetrix?
NeuroMetrix's mailing address is 4B Gill Street, Woburn, MA and company can be reached via phone at +7 818909989.
NeuroMetrix company profile:

NeuroMetrix, Inc.
neurometrix.comNASDAQ
26
Medical - Devices
Healthcare
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Woburn, MA 01801
CIK: 0001289850
ISIN: US6412558800
CUSIP: 641255807